Cibc Private Wealth Group, LLC Astrazeneca PLC Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,218,863 shares of AZN stock, worth $595 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
8,218,863
Previous 8,105,996
1.39%
Holding current value
$595 Million
Previous $531 Million
13.74%
% of portfolio
1.18%
Previous 1.01%
Shares
34 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.13 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.94 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.58 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.3 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.26 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...